Form 8-K - Current report:
SEC Accession No. 0001193125-26-419829
Filing Date
2026-10-13
Accepted
2026-10-13 09:28:22
Documents
43
Period of Report
2026-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrt-20261013.htm   iXBRL 8-K 169071
2 EX-2.1 tcrt-ex2_1.htm EX-2.1 1186905
3 EX-3.1 tcrt-ex3_1.htm EX-3.1 163857
4 EX-3.2 tcrt-ex3_2.htm EX-3.2 156713
5 EX-10.1 tcrt-ex10_1.htm EX-10.1 382348
6 EX-10.2 tcrt-ex10_2.htm EX-10.2 213804
7 EX-10.3 tcrt-ex10_3.htm EX-10.3 56107
8 EX-99.1 tcrt-ex99_1.htm EX-99.1 33444
9 EX-99.2 tcrt-ex99_2.htm EX-99.2 32289
10 GRAPHIC tcrt-ex99_1s1.jpg GRAPHIC 183232
11 GRAPHIC tcrt-ex99_1s2.jpg GRAPHIC 924266
12 GRAPHIC tcrt-ex99_1s3.jpg GRAPHIC 473237
13 GRAPHIC tcrt-ex99_1s4.jpg GRAPHIC 325671
14 GRAPHIC tcrt-ex99_1s5.jpg GRAPHIC 441479
15 GRAPHIC tcrt-ex99_1s6.jpg GRAPHIC 313564
16 GRAPHIC tcrt-ex99_1s7.jpg GRAPHIC 376277
17 GRAPHIC tcrt-ex99_1s8.jpg GRAPHIC 475406
18 GRAPHIC tcrt-ex99_1s9.jpg GRAPHIC 409560
19 GRAPHIC tcrt-ex99_1s10.jpg GRAPHIC 320308
20 GRAPHIC tcrt-ex99_1s11.jpg GRAPHIC 387092
21 GRAPHIC tcrt-ex99_1s12.jpg GRAPHIC 389748
22 GRAPHIC tcrt-ex99_1s13.jpg GRAPHIC 404660
23 GRAPHIC tcrt-ex99_1s14.jpg GRAPHIC 323312
24 GRAPHIC tcrt-ex99_1s15.jpg GRAPHIC 159446
25 GRAPHIC tcrt-ex99_1s16.jpg GRAPHIC 427362
26 GRAPHIC tcrt-ex99_1s17.jpg GRAPHIC 330595
27 GRAPHIC tcrt-ex99_1s18.jpg GRAPHIC 181817
28 GRAPHIC tcrt-ex99_1s19.jpg GRAPHIC 404300
29 GRAPHIC tcrt-ex99_1s20.jpg GRAPHIC 406391
30 GRAPHIC tcrt-ex99_1s21.jpg GRAPHIC 156729
31 GRAPHIC tcrt-ex99_1s22.jpg GRAPHIC 414341
32 GRAPHIC tcrt-ex99_1s23.jpg GRAPHIC 319401
33 GRAPHIC tcrt-ex99_1s24.jpg GRAPHIC 385635
34 GRAPHIC tcrt-ex99_1s25.jpg GRAPHIC 376582
35 GRAPHIC tcrt-ex99_1s26.jpg GRAPHIC 294343
  Complete submission text file 0001193125-26-419829.txt   16113075

Data Files

Seq Description Document Type Size
36 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcrt-20261013.xsd EX-101.SCH 53226
46 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20261013_htm.xml XML 4900
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 261455182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)